Introduction
Human leukocyte antigen (HLA) specificities were originally distinguished by allosera from multiparous women or individuals with multiple blood transfusions using cell-based testing strategies. HLA typing is currently performed by more accurate and specific molecular methods that assay nucleotide sequences. The IMGT/HLA database was developed to catalog the growing number of known HLA gene sequences 1 . While the naming of HLA sequences has its roots in the antigen nomenclature from serologic typing 2 , new HLA alleles are named based on sequence similarity to known alleles.
The United Network for Organ Sharing (UNOS) organ allocation system UNet utilizes donor and recipient HLA typing information and a list of unacceptable HLA antigens determined from antibody assays to perform virtual crossmatch as part of organ offers 3, 4 . While the more specific IMGT/HLA allele nomenclature is used to interpret DNA-based typing data, only serologic antigen equivalents are accepted by the UNet 5 .
Antigen groups are used to represent unacceptable HLA specificities because a single allo-HLA antibody may react similarly against several distinct HLA alleles within the same antigen group.
Histocompatibility labs face a data management challenge in mapping molecular-level HLA data to UNOS antigen equivalents for entry into UNet. While the Organ Procurement and Transplantation Network (OPTN) published a policy document in 2003 with general guidelines for mapping molecular data to antigen equivalents 6 , there is a need to automate the mapping process with a standardized mapping table that includes 8 every IMGT/HLA allele. UNOS deemed it infeasible to maintain such a table at the time.
Because of the difficulty in synthesizing antigen equivalency information from multiple reference data sources, there is likely to be some variability in reporting of HLA typing results into UNOS systems, even among commercial typing platforms.
A rapid turnaround for HLA typing is necessary for limiting cold ischemic time, therefore deceased donors are typed by sequence-specific primer (SSP), sequence-specific oligonucleotide probe (SSOP), or real-time polymerase chain reaction (PCR) based methods rather than next-generation sequencing (NGS). These methods rarely achieve allele-level specificity. Hence, there is also a need to interpret ambiguous HLA typings in the context of population HLA frequencies, as OPTN guidelines call for reporting UNOS antigens based on the most common HLA allele.
To meet these challenges in HLA data reporting for virtual crossmatch, we were inspired by matching systems for hematopoietic stem cell transplantation (HSCT) that have the capability to represent HLA typing data in IMGT/HLA allele nomenclature and match to donors whose HLA is represented in antigen nomenclature 7 . . An example Python script that illustrates how to access the web services is also provided in our GitHub source code repository (https://github.com/lgragert/hla-who-to-unos). For advanced users who wish to run the conversion tool locally, a Python command line tool and pip installable package "transplanttoolbox-allan" are also available (https://pypi.org/project/transplanttoolboxallan/).
Antigen Frequencies and Similarity Index Calculation
Reference antigen frequencies for 4 broad US race/ethnic categories (CAU, AFA, HIS, and API) were generated by mapping NMDP haplotype frequencies to UNOS antigen equivalencies. To assess accuracy in antigen assignments we used a normalized similarity index, "I F " 20 , to compare the converted NMDP antigen frequencies to an independent antigen-level frequency dataset of previous UNOS donors 21 that is currently used operationally as the reference panel for measuring CPRA values.
Results

Mapping Serological Specificities for IMGT/HLA Alleles Based on UNOS Guidelines
An algorithm was designed to map IMGT/HLA alleles to antigens following the UNOS guidelines. Our interpretation of the rule precedence for antigen mapping guidelines is shown as a schematic diagram in Figure 1 . The antigen assignments found in tables from UNOS histocompatibility committee updates, UNOS antigen equivalency tables for specific alleles (Table 1 : Suggested UNOS serology equivalents for molecular types 1 4 (2003)) 6 , and 4-digit antigens defined by UNOS were given the highest precedence 5 .
For the next level of precedence, WHO-assigned antigens from the WMDA file were assigned (see Rule 3 in Table 1 Table 2 .
Most Probable Antigen for Ambiguous HLA Typing
As per OPTN guidelines, for a group of possible alleles in an ambiguous HLA typing, the serologic equivalent of the most common antigen should be entered. We apply reference population-specific allele frequencies from the NMDP population categories to make the assignment. We show that for a particular ambiguous HLA typing, the most probable antigen for the B locus may vary depending on the broad race/ethnic category selected (Table 3) .
"ALLAN": IMGT/HLA ALLele to UNOS ANtigen conversion tool
The conversion functions described above are available via the ALLAN web tool at http://www.transplanttoolbox.org. When the HLA typing is unambiguous, users may select to enter either a single allele or a list of alleles. When the HLA typing contains typing ambiguity, users may enter the typing either in GL string or MAC format ( Table   1  6 3). The output shows the UNOS antigen assignments and Bw4/6 epitopes. Entry of ambiguous HLA typings requires the selection of a US race/ethnic group and returns the probability distribution of all the possible antigens considering the allele frequencies in the selected race/ethnic group. A complete user guide for the tool is available on the website. For advanced users, we also developed a Python script as a command line tool with similar functionality, which can be accessed via our GitHub repository (https://github.com/lgragert//hla-who-to-unos). We have also developed web services as a programming interface for researchers and laboratory information management systems. Client applications such as HLA typing software platforms or other lab information systems can send HLA typing and race/ethnicity information to the service, and UNOS antigens (including probabilities) are returned. The endpoint URLs and commands for these services are shown in Table 4 . The WMDA does provide quarterly updates, but again vendors are left with choosing between "Unambiguous associations," "Possible associations," "Assumed associations,"
Antigen Mappings in Commercially Available
and "Expert assigned exceptions," and have to reconcile these options with customer specific requests. As a result, some antigen mappings made by these software packages differ from those recommended by UNOS. A list of discrepancies from apparent UNOS guidelines, apart from the missing mappings, is shown in Table 5 . The commercial software vendors are in agreement that the issues arising from independent maintenance and interpretation of antigen conversion rules will be alleviated by having a consensus set of mappings.
Reference Antigen Frequencies for Six HLA Loci in 4 Broad US Races
To validate the antigen assignments, we converted published NMDP high resolution haplotype frequencies 14 into antigen equivalents and compared antigen frequencies at each HLA locus to the UNOS CPRA HLA reference panel. Antigen-level NMDP frequency tables for 4 US broad race/ethnic categories are available as Supplementary   Table 3 . The normalized "I F " similarity index for these races ranged from 0.85 to 0.97, indicating accuracy in antigen assignments (Table 6 ). One cause of disparity between panels was that the UNOS DQ typing data was more often reported as broad DQ1
antigens rather than split DQ5 and DQ6 antigens. Meanwhile, the only high resolution IMGT/HLA alleles in the NMDP panel that mapped to broad DQ1 were the relatively uncommon alleles DQB1*06:11 and DQB1*06:12.
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Discussion
The OPTN guidelines for HLA allele to antigen mapping require that histocompatibility labs refer to several different data sources which as we have shown here can lead to differences in antigen assignment. To streamline this process, we present a complete mapping table between all current IMGT/HLA alleles and UNOS antigens that was developed based on published OPTN guidelines. This conversion table report gives a standardized source for antigen mapping that can be updated in tandem with every new IMGT/HLA database release.
Our web tool, ALLAN, offers a convenient mapping of HLA typing data to UNOS antigens for entry into UNet, including resolving HLA typing ambiguities in antigen assignments as shown in Table 3 . This will aid in streamlining HLA typing that is performed for deceased donors, which has limited time for experimentally resolving ambiguities. Molecular methods such as SSP may not always resolve null expression variants in time, however, our tool helps in predicting the probability of null alleles and therefore a blank antigen for a specified population.
One potential cause of unexpected positive tissue crossmatch 22 . If the allele lacked a WHO assignment, the 2008 HLA dictionary would be used to assign a B62. For the UNOS assignment to become B62, the WHO antigen would need to change or UNOS would need to specify an exception to the rule. In summary, these complex cases cannot all be sorted out here. We believe such decisions are best left to UNOS, WHO, or the next HLA Dictionary.
Standardized antigen assignments for molecular typing are necessary for the UNOS organ allocation system to evolve to incorporate DNA-based HLA assignments and epitope-based matching strategies 32 . We anticipate future updates to our tool to support changes in the UNOS CPRA to include antigens for the DQA1, DPA1, and DPB1 loci.
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These loci together account for >60% of the unacceptable antigens in candidates with CPRA > 99% 33, 34 . We intend to develop additional tools that would allow the NMDP high resolution frequency panel to be used for allele-level CPRA calculations incorporating these additional loci. Imputation tools based on NMDP frequency data are also useful for estimating amino acid assignments from antigen-level data to perform epitope analysis with tools such as PIRCHE: predicted indirectly recognizable HLA epitopes 35 .
The antigen mapping tools we developed here will take UNOS one step closer to their long-term goal of maximally utilizing HLA molecular typing data in solid organ allocation systems. *Rule notation is used in Figure 1 as well as supplementary given to UNOS resources, followed by WHO antigens, the HLA dictionary, and the WMDA antigen file. If an antigen could not be assigned to an allele from these antigen equivalency reference sources, then the first-field of the IMGT/HLA allele name was assigned as the antigen.
